Cardiovascular an Echocardiographic Assessment in Hypertension During Pregnancy
Information source: HaEmek Medical Center, Israel
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Pregnancy
Phase: Phase 3
Status: Recruiting
Sponsored by: HaEmek Medical Center, Israel Official(s) and/or principal investigator(s): Limor I Bushari, Principal Investigator, Affiliation: Heart Institute, Ha'Emek Medical Center
Overall contact: Limor I Bushari, MD, Phone: 9724502000741, Email: limor_il@clalit.org.il
Summary
Cardiovascular & echocardiographic assessment in pregnant women with hypertension during
their pregnancy in comparison to Pregnant normotensive women.
Clinical Details
Official title: Hypertension During Pregnancy: Cardiovascular & Echocardiographic Assessment: CREATION - P (01)
Study design: Observational Model: Cohort, Time Perspective: Prospective
Primary outcome: Hypertension impact on cardiovascular echocardiographic parameters and obstetric parameters in pregnant women with or without treatment
Secondary outcome: Primary outcome, Impact of alfa methyl dopa and labetolol on cardiovascular parameters in pregnant women
Detailed description:
Cardiovascular & echocardiographic assessment in pregnant women with hypertension during
their pregnancy in comparison to Pregnant normotensive women. Also,comparing
echocardiographic parameters in hypertensive pregnant women being treated with either alfa
methyl dopa or labetolol.
Eligibility
Minimum age: 18 Years.
Maximum age: 60 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- hypertension during pregnancy: Chronic or pregnancy induced
Exclusion Criteria:
- Inability to sign informed consent
Locations and Contacts
Limor I Bushari, MD, Phone: 9724502000741, Email: limor_il@clalit.org.il
Ha'Emek Medical Center, Afula 18101, Israel; Recruiting Limor I Bushari, MD, Phone: 972502000741, Email: limor_il@clalit.org.il Nachum Zohar, Phone: 972547696562, Email: nachun_zo@clalit.org.il Limor I Bushari, MD, Principal Investigator Raed Salim, MD, Sub-Investigator Nachum Zohar, MD, Sub-Investigator
Additional Information
Starting date: June 2009
Last updated: February 11, 2010
|